You may have seen the news (7th June 2021) that the American FDA (Food and  Drug Agency) has approved aducunamab (Aduhelm) for the treatment of mild Alzheimer’s Disease.  This is the first new treatment for Alzheimer’s Disease licensed in some 20 years but is not yet licensed or available for use in the UK and we […]